These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 10751136

  • 1. Human immunodeficiency virus type 1 p24 concentration measured by boosted ELISA of heat-denatured plasma correlates with decline in CD4 cells, progression to AIDS, and survival: comparison with viral RNA measurement.
    Ledergerber B, Flepp M, Böni J, Tomasik Z, Cone RW, Lüthy R, Schüpbach J.
    J Infect Dis; 2000 Apr; 181(4):1280-8. PubMed ID: 10751136
    [Abstract] [Full Text] [Related]

  • 2. Measurement of HIV-1 p24 antigen by signal-amplification-boosted ELISA of heat-denatured plasma is a simple and inexpensive alternative to tests for viral RNA.
    Schüpbach J.
    AIDS Rev; 2002 Apr; 4(2):83-92. PubMed ID: 12152521
    [Abstract] [Full Text] [Related]

  • 3. Heat-denatured human immunodeficiency virus type 1 protein 24 antigen: prognostic value in adults with early-stage disease.
    Sterling TR, Hoover DR, Astemborski J, Vlahov D, Bartlett JG, Schupbach J.
    J Infect Dis; 2002 Oct 15; 186(8):1181-5. PubMed ID: 12355373
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospective evaluation of amplification-boosted ELISA for heat-denatured p24 antigen for diagnosis and monitoring of pediatric human immunodeficiency virus type 1 infection.
    Nadal D, Böni J, Kind C, Varnier OE, Steiner F, Tomasik Z, Schüpbach J.
    J Infect Dis; 1999 Oct 15; 180(4):1089-95. PubMed ID: 10479135
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [The prognostic markers of HIV infection progression. A study of the p24 antigen in a cohort of 251 patients].
    Rubio Caballero M, Nogués Biau A, Falguera Sacrest M, Puig Ganau T.
    An Med Interna; 1999 Sep 15; 16(9):447-50. PubMed ID: 10609356
    [Abstract] [Full Text] [Related]

  • 9. Markers of response to zidovudine monotherapy among treated HIV seroconverters. Italian Seroconversion Study.
    Rezza G, Galai N, Pezzotti P, Vlahov D, Graham NM, Viale P, Angarano G.
    Antivir Ther; 1997 Jul 15; 2(3):167-74. PubMed ID: 11322271
    [Abstract] [Full Text] [Related]

  • 10. Rapid clearance of virus after acute HIV-1 infection: correlates of risk of AIDS.
    Blattner WA, Oursler KA, Cleghorn F, Charurat M, Sill A, Bartholomew C, Jack N, O'Brien T, Edwards J, Tomaras G, Weinhold K, Greenberg M.
    J Infect Dis; 2004 May 15; 189(10):1793-801. PubMed ID: 15122515
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Evaluation of two commercially available, inexpensive alternative assays used for assessing viral load in a cohort of human immunodeficiency virus type 1 subtype C-infected patients from South Africa.
    Stevens G, Rekhviashvili N, Scott LE, Gonin R, Stevens W.
    J Clin Microbiol; 2005 Feb 15; 43(2):857-61. PubMed ID: 15695692
    [Abstract] [Full Text] [Related]

  • 15. Effector HIV-specific cytotoxic T-lymphocyte activity in long-term nonprogressors: associations with viral replication and progression.
    Keoshkerian E, Ashton LJ, Smith DG, Ziegler JB, Kaldor JM, Cooper DA, Stewart GJ, Ffrench RA.
    J Med Virol; 2003 Dec 15; 71(4):483-91. PubMed ID: 14556259
    [Abstract] [Full Text] [Related]

  • 16. Plasma levels of viro-immunological markers in HIV-infected and non-infected Ethiopians: correlation with cell surface activation markers.
    Messele T, Brouwer M, Girma M, Fontanet AL, Miedema F, Hamann D, Rinke de Wit TF.
    Clin Immunol; 2001 Feb 15; 98(2):212-9. PubMed ID: 11161977
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Optimized virus disruption improves detection of HIV-1 p24 in particles and uncovers a p24 reactivity in patients with undetectable HIV-1 RNA under long-term HAART.
    Schüpbach J, Tomasik Z, Knuchel M, Opravil M, Günthard HF, Nadal D, Böni J, Swiss HIV Cohort Study, Swiss HIV Mother + Child Cohort Study.
    J Med Virol; 2006 Aug 15; 78(8):1003-10. PubMed ID: 16789014
    [Abstract] [Full Text] [Related]

  • 20. Serum neopterin, an immune activation marker, independently predicts disease progression in advanced HIV-1 infection.
    Mildvan D, Spritzler J, Grossberg SE, Fahey JL, Johnston DM, Schock BR, Kagan J.
    Clin Infect Dis; 2005 Mar 15; 40(6):853-8. PubMed ID: 15736019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.